Additional Information
Market: OTCBB
Sector: Pharmaceuticals & Biotechnology
EPIC: BONU
Latest Price: $0.10  (0,00%)
52-week High: $0.00
52-week Low: $0.00
Market Cap: $10.30M
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
BioNeutral Group
www.bioneutralgroup.com

Headquartered at the New Jersey Institute of Technology in Newark, New Jersey is a Life Science specialty chemical company with a focus on commercializing a game changing environmentally safe combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous microorganisms including bacteria, viruses, mold and difficult to eliminate health threatening spores. Using this approach BioNeutral has developed a cutting edge disruptive family of products initially focused in the health care arena and in National Defense . These ground breaking products have been approved for use in Germany, US/EPA approval is expected in mid 2010.

Pdf

BioNeutral develops new line of anti-bacterial products for industrial purposes

15th Oct 2010, 7:17 am The new product group expands BioNeutral's product offering and footprint in the industrial manufacturing sector

BioNeutral Group (OTCBB:BONU) said it has developed a new antimicrobial technology platform that kills bacteria quickly and efficiently, designed specifically for industrial uses.

The new platform expands BioNeutral's product offering and footprint in the industrial manufacturing sector, especially where hydrocarbons and hydrocarbon emulsions are used in metal forming, grinding, and the treatment and specialty petrochemical industries, the company said.

"Our original Ygiene antimicrobials are water based and as such are not readily compatible with hydrocarbon systems. In contrast, our new antimicrobials are miscible with oil type materials," said chief scientist for BioNeutral, Dr. Andy Kielbania.

This means that bacterial growth in industrial oil-based products could be controlled, creating the potential to reduce production down time and eliminate industrial hygiene issues in the work environment.

Testing of the new products show that there was zero concentration of harmful bacteria as quickly as one minute after application, for as long as five days after initial antimicrobial treatment.

According to the company, the products could also be of use in a wide variety of plastics, such as polyethylene, polypropylene, polyester and polyvinyl chloride.

BioNeutral's existing products, Ygiene and Ogiene, kill germs and clean surfaces and have been proven effective in surface, water and airborne applications. The Ygiene brand products have been submitted to the EPA for approval for sale in the United States and have already been approved in Germany, the UK, France and Sweden.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.